Zoetis (ZTS) Prepaid Assets (2012 - 2026)
Zoetis' (ZTS) quarterly Prepaid Assets came in at $477.0 million in Q1 2026, up 10.93% year-on-year from $430.0 million in Q1 2025, and up 6.0% on a QoQ basis from $450.0 million in Q4 2025.
Zoetis (ZTS) Prepaid Assets (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Prepaid Assets data on file, last reported at $477.0 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 10.93% year-over-year to $477.0 million in Q1 2026; TTM through Mar 2026 was $477.0 million, a 10.93% increase from a year earlier, with the FY2025 full-year figure at $450.0 million, up 19.36% from the prior year.
- Prepaid Assets for Q1 2026 stood at $477.0 million, up from $450.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for ZTS reached as high as $552.0 million in Q3 2022 and fell as low as $365.0 million in Q4 2022.
- Historically, Prepaid Assets has averaged $451.1 million across 5 years, with a median of $443.0 million in 2023.
- Across the five-year window, Prepaid Assets jumped 44.88% in 2022 and declined 15.4% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $365.0 million in 2022, then increased by 18.9% to $434.0 million in 2023, then fell by 13.13% to $377.0 million in 2024, then advanced by 19.36% to $450.0 million in 2025, then increased by 6.0% to $477.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $477.0 million in Q1 2026, $450.0 million in Q4 2025, and $493.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 477.00 Mn |
| Dec 31, 2025 | 450.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 509.00 Mn |
| Mar 31, 2025 | 430.00 Mn |
| Dec 31, 2024 | 377.00 Mn |
| Sep 30, 2024 | 427.00 Mn |
| Jun 30, 2024 | 467.00 Mn |
| Mar 31, 2024 | 440.00 Mn |
| Dec 31, 2023 | 434.00 Mn |
| Sep 30, 2023 | 467.00 Mn |
| Jun 30, 2023 | 443.00 Mn |
| Mar 31, 2023 | 411.00 Mn |
| Dec 31, 2022 | 365.00 Mn |
| Sep 30, 2022 | 552.00 Mn |
| Jun 30, 2022 | 503.00 Mn |
| Mar 31, 2022 | 423.00 Mn |
| Dec 31, 2021 | 389.00 Mn |
| Sep 30, 2021 | 381.00 Mn |
| Jun 30, 2021 | 418.00 Mn |